Risk for Type 2 Diabetes Increased for Children After SARS-CoV-2 Infection
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Oct. 16, 2024 -- The risk for an incident diagnosis of type 2 diabetes (T2D) is increased in the six months following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, according to a study published online Oct. 14 in JAMA Network Open.
Margaret G. Miller, from the Case Western Reserve University School of Medicine in Cleveland, and colleagues conducted a retrospective cohort study using electronic health records to examine whether the risk for incident T2D diagnosis is increased during the six months following SARS-CoV-2 infection in pediatric patients aged 10 to 19 years. The study population included 613,602 patients: 306,801 with COVID-19 and 306,801 with other respiratory infections after propensity score matching.
The researchers found a significant increase in the risk for a new diagnosis of T2D from the day of infection to one, three, and six months after COVID-19 diagnosis compared with the matched cohort (risk ratios, 1.55, 1.48, and 1.58 at one, three, and six months, respectively). In the subpopulation classified as having overweight or obesity, results were similar (risk ratios, 2.07, 2.00, and 2.27 at one, three, and six months, respectively); results were also similar in the subpopulation with hospitalization (risk ratios, 3.10, 2.74, and 2.62 at one, three, and six months, respectively). When excluding patients diagnosed during the interval from the index date to one month after infection, a similar elevation in risk was seen at three and six months.
"Understanding the role that SARS-CoV-2 plays in pediatric T2D incidence will add an important component to consideration of the risks and benefits of preventing SARS-CoV-2 infection in children," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted October 2024
Further Support and Information on COVID-19
Read this next
GLP-1 Receptor Agonist Use Linked to Lower Mortality in Seniors With Cancer, T2D
THURSDAY, July 24, 2025 -- For older patients with cancer and type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with lower all-cause...
Random Forest AI Model Superior for Inpatient Mortality Prognostication in Cirrhosis
THURSDAY, July 24, 2025 -- For inpatients with cirrhosis, a machine learning (ML) model using random forest (RF) analysis is superior for prediction of inpatient mortality...
Inflammation and Nutrition-Based Scores Tied to Prognosis of Low-Risk Myelodysplastic Syndrome
THURSDAY, July 24, 2025 -- The Prognostic Nutritional Index (PNI) and systemic oxidative stress (SOS) score are independently associated with poorer prognosis of low-risk...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.